The study concluded that GLP-1 RAs did not trigger new clinical SLE manifestations above expected background rates while producing significant weight loss benefits
Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
Privately prescribed GLP-1s may not appear on the patients medical history so if a patient presents with these symptoms, healthcare professionals should enquire about GLP-1 use
Semaglutide functions as a GLP-1 receptor agonist, meaning it activates the same receptors as your bodys natural GLP-1
While these gummies do not contain prescription GLP-1 medications, they are designed to nutritionally support the gut and metabolic pathways involved in satiety
Amylin and GLP-1 are two different hormones that both reduce appetite but through different brain pathways